EP1747 - LBA_ECE_1003 - TMC from Glycyrrhiza uralensis suppresses hypoxic tumor microenvironment by co-targeting the HIF-1α–neuroendocrine axis and angiogenic signaling in colorectal cancer
Results suggest that TMC may serve as a potential therapeutic candidate for targeting hypoxia-associated neuroendocrine signaling and angiogenesis, and demonstrates that TMC acts as a multi-target inhibitor that suppresses hypoxia-driven angiogenic signaling while simultaneously modulating the neuroendocrine stress axi...